- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BULLION GOLD DISCOVERIES Aktie jetzt für 0€ handeln | |||||
| 09.07. | Bullion Gold Discoveries Corp: Bullion Gold private placement | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp: Bullion Gold samples 5.4 g/t Au at Terragold project | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp.: Bullion Reports 5.4 g/t Au and 5.0 g/t Ag in Surface Grab Sample and Commences Validation Drilling at Terragold | 395 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 30, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to provide an exploration update from Bullion's flagship and... ► Artikel lesen | |
| 23.06. | Bullion Gold Discoveries Corp: Bullion shareholders approve all matters at AGM | 1 | Stockwatch | ||
| 23.06. | Bullion Gold Discoveries Corp.: Bullion Announces Results of Annual General Meeting | 757 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 22, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the voting results from its Annual General Meeting... ► Artikel lesen | |
| 18.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 18.06.2026 | 431 | Xetra Newsboard | The following instruments on XETRA do have their first trading 18.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.06.2026
Aktien
1 SE0029278985 Tangen Industrikapital... ► Artikel lesen | |
| 17.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.06.2026 | 428 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.06.2026ISIN NameCA1202272029 BULLION... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp: Bullion Gold closes $2-million private placement | 1 | Stockwatch | ||
| 17.06. | XFRA ISIN CHANGE | 287 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1202272029 Bullion Gold Discoveries Corp. 17.06.2026 CA1199331093 Bullion Gold Discoveries Corp. 18.06.2026 Tausch... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp.: Bullion Closes $2M Private Placement | 431 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it has closed its previously announced non-brokered... ► Artikel lesen | |
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 364 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 16.06. | XFRA B4R: AUSSETZUNG/SUSPENSION | 180 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBULLION GOLD RES... ► Artikel lesen | |
| 13.06. | Bullion Gold Resources Corp (2): Bullion Gold name change to Bullion Gold Discoveries | 6 | Stockwatch | ||
| 12.06. | Bullion Gold Resources Corp. kündigt Namensänderung an | 1 | GoldSeiten.de | ||
| 12.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources to change name | 1 | Stockwatch | ||
| 11.06. | Bullion Gold Resources Corp.: Bullion Announces Name Change to Bullion Gold Discoveries Corp | 588 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 11, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it will complete a name change from "Bullion... ► Artikel lesen | |
| 09.06. | Bullion Gold Resources Corp (2): Bullion Gold moves field crew to Terragold | 1 | Stockwatch | ||
| 09.06. | Bullion Gold Resources Corp.: Bullion Mobilizes Field Team to Terragold Project and Increases Private Placement to $2 Million | 423 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that its field team has been mobilized to Bullion's... ► Artikel lesen | |
| 02.06. | Bullion Gold Resources Corp (2): Bullion arranges $1.5-million private placement | 2 | Stockwatch | ||
| 02.06. | Bullion Gold Resources Corp.: Bullion Announces $1.5 Million Private Placement | 395 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 2, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce a private placement of up to 16,666,667 units of... ► Artikel lesen |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 37,660 | +1,67 % | Märkte am Morgen: Gold, SanDisk, eBay, Alphabet, Deutsche Telekom, Qiagen | Der DAX hat in dieser Woche bisher jeden Tag ein neues Rekordhoch markiert - so auch gestern. 26.403 Punkte lautet die Marke, die wir uns merken müssen. Wie lange, wird sich zeigen. Gestern gab es jedenfalls... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 134,51 | -0,03 % | Apogee Therapeutics: Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates | AbbVie to acquire Apogee for $135.11 per share in cash for total equity value of approximately $10.9 billion, positioning differentiated immunology portfolio to reach more patients worldwide Positive... ► Artikel lesen | |
| EVOTEC | 3,548 | -7,84 % | EQS-News: Evotec SE: Evotec und Odyssey Therapeutics starten KI-gestützte F&E-Kooperation in Autoimmun- und Entzündungserkrankungen | EQS-News: Evotec SE
/ Schlagwort(e): Sonstiges
Evotec und Odyssey Therapeutics starten KI-gestützte F&E-Kooperation in Autoimmun- und Entzündungserkrankungen
06.08.2026... ► Artikel lesen | |
| TANGO THERAPEUTICS | 25,790 | +0,82 % | Tango Therapeutics, Inc.: Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 data Phase 1/2 data from combination... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 374,91 | -2,96 % | Praxis Precision Medicines, Inc. - 10-Q, Quarterly Report | ||
| SUMMIT THERAPEUTICS | 14,650 | -2,98 % | H.C. Wainwright reiterates Neutral stock rating on Summit Therapeutics | ||
| SEPTERNA | 45,700 | -5,17 % | Septerna, Inc.: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results | Phase 1 Clinical Trial Ongoing for SEP-479, an Oral Small Molecule PTH1R Agonist SEP-479 Observed Clinical Pharmacokinetic Profile Supports Once-Daily Dosing; SAD / MAD Data Expected in Q1 2027 Cash... ► Artikel lesen | |
| CULLINAN THERAPEUTICS | 20,010 | +2,09 % | Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports.Alamar Biosciences Inc.... ► Artikel lesen | |
| BEAM THERAPEUTICS | 26,410 | -1,12 % | H.C. Wainwright reiterates Beam Therapeutics stock rating at buy | ||
| DYNE THERAPEUTICS | 26,060 | -0,42 % | PetAg expands Tractor Supply distribution of supplements, life-stage nutrition: The company's Dyne Soft Chews and Esbilac ... | ||
| COGENT BIOSCIENCES | 37,750 | -3,16 % | Cogent Biosciences, Inc. - 10-Q, Quarterly Report | ||
| CG ONCOLOGY | 75,00 | -2,58 % | CG Oncology Inc.: CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates | PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC anticipated in the near-termBLA completion for HR BCG-unresponsive NMIBC expected... ► Artikel lesen | |
| TREVI THERAPEUTICS | 18,410 | +3,84 % | Trevi Therapeutics, Inc.: Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates | Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 25,940 | -1,29 % | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| ERASCA | 18,020 | -3,07 % | Erasca, Inc.: Erasca Reports Second Quarter 2026 Business Updates and Financial Results | Updated ERAS-0015 data in U.S. trial highlighted compelling monotherapy efficacy in 2L+ KRAS G12X PDAC and continued favorable tolerability, as well as further advancement of panitumumab CRC combination... ► Artikel lesen |
Das Unternehmen BULLION GOLD DISCOVERIES CORPORATION kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (-0,47 %) liegt der Kurs bei 0,043 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD DISCOVERIES CORPORATION finden Sie auf Wallstreet Online.